AUTOANTIBODY FORMATION AFTER BONE-MARROW TRANSPLANTATION - A COMPARISON BETWEEN AUTOLOGOUS AND ALLOGENEIC GRAFTS

被引:21
|
作者
SANMARCO, M
VIALETTES, B
MARANINCHI, D
BERNARD, D
机构
[1] Laboratoire d'Immunologic Facullé de Médecine, 13385, Marseille, Cédex 5
[2] Service de Médecine Interne, Hôpital de la Timone, 13385, Marseille, Cédex 5, 254, Rue St-Pierre
[3] Centre de Greffe de Moelle Osseuse, Institut J, 13277, Marseille, Cédex 9, Paoli-1. Calmettes, Bd de Ste Marguerite
关键词
BONE MARROW TRANSPLANTATION; AUTOANTIBODIES;
D O I
10.3109/08916939108994702
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Various autoantibodies were screened in 11 allogeneic, 14 autologous bone marrow transplanted patients and 11 healthy controls. Except anti-mitochondria antibodies, autoantibodies were found with similar frequencies after allogeneic and autologous transplantation. Moreover, 50% of autoantibodies were already present before transplantation. These results suggest that factors other than allogeneic reaction could be responsible for autoantibody formation after bone marrow transplantation, in particular, pre-graft conditioning treatment and/or viral and bacterial infection. Nevertheless, the number of patients with 2 or more autoantibodies was significantly higher after allogeneic than after autologous grafting (respectively, 82% and 36.7%; P<0.05). Forty percent of allografted but none of autografted patients were still positive at 12 months post graft. So, allogeneic reaction could play a role in intensity of humoral response and its maintenance for a long period. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
  • [1] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RECURRENCE OF LEUKEMIA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    SCHWELLA, N
    SCHWERDTFEGER, R
    KONIG, V
    BLASCZYK, R
    SCHMID, H
    SCHMIDTWOLF, I
    HENZE, G
    SIEGERT, W
    TRANSPLANTATION, 1994, 57 (08) : 1263 - 1265
  • [2] INFECTIONS IN BONE-MARROW TRANSPLANTATION - A COMPARISON BETWEEN ALLOGENEIC AND AUTOLOGOUS GRAFT
    TURA, S
    RICCI, P
    BANDINI, G
    CALORI, E
    ALBERTAZZI, L
    ROSTI, G
    VERLICCHI, F
    FORALOSSO, AM
    POLETTI, G
    INFECTIONS AND HAEMORRHAGE IN ACUTE LEUKAEMIA, 1989, 2 : 127 - 136
  • [3] CYTOMEGALO-VIRUS INFECTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH COMPARISON TO INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    WINGARD, JR
    CHEN, DYH
    BURNS, WH
    FULLER, DJ
    BRAINE, HG
    YEAGER, AM
    KAISER, H
    BURKE, PJ
    GRAHAM, ML
    SANTOS, GW
    SARAL, R
    BLOOD, 1988, 71 (05) : 1432 - 1437
  • [4] ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    DEEG, HJ
    CANADIAN FAMILY PHYSICIAN, 1988, 34 : 2489 - 2498
  • [5] AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    ASCENSAO, JL
    AHMED, T
    ARLIN, ZA
    NEW YORK STATE JOURNAL OF MEDICINE, 1986, 86 (04) : 178 - 183
  • [6] CLONALITY OF BONE-MARROW REPOPULATION AFTER ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    BUSQUE, L
    MARAGH, M
    DEHART, D
    MCGARIGLE, C
    VOSE, J
    ARMITAGE, J
    MEISINGER, D
    WHEELER, C
    GAINES, L
    BELANGER, R
    HABEL, F
    DUNBAR, C
    CHAMPAGNE, M
    GROSS, W
    WEINSTEIN, H
    ANTIN, JH
    GILLIAND, DG
    BLOOD, 1993, 82 (10) : A457 - A457
  • [7] INTERSTITIAL PNEUMONIA AFTER ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    FUNADA, H
    HARADA, M
    YOSHIDA, T
    HATTORI, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1984, 14 : 519 - 530
  • [8] ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOMA RELAPSING AFTER AUTOLOGOUS MARROW TRANSPLANTATION
    SCHOUTEN, HC
    ARMITAGE, JO
    KLASSEN, LW
    VAUGHAN, WP
    BIERMAN, PJ
    WEISENBURGER, D
    KESSINGER, A
    BONE MARROW TRANSPLANTATION, 1989, 4 (01) : 119 - 121
  • [10] ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN AML
    SANTOS, GW
    LEUKEMIA, 1992, 6 : 102 - 103